Sukmin Han
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A novel multi-target compound mitigates amyloid plaques, synaptic deficits, and neuroinflammation in Alzheimer's disease models.
Journal: Archives of pharmacal research
Published: March 10, 2025
RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer's disease mouse models.
Journal: Animal cells and systems
Published: February 11, 2025
N5-((perfluorophenyl)amino)glutamine regulates BACE1, tau phosphorylation, synaptic function, and neuroinflammation in Alzheimer's disease models.
Journal: Bioscience trends
Published: January 26, 2025
Ramalin Ameliorates Alzheimer's Disease Pathology by Targeting BACE1, HDAC6, and MAPK Pathways.
Journal: MedComm
Published: October 08, 2024
L-type Ca2+ channels mediate regulation of glutamate release by subthreshold potential changes.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 15, 2023
Distinct synaptic vesicle recycling in inhibitory nerve terminals is coordinated by SV2A.
Journal: Progress in neurobiology
Published: December 16, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026